Myprimose (Ethinylestradiol, Etonogestrel)

Ethinylestradiol, the active ingredient in Myprimose, is a combined estrogen‑progestogen contraceptive presented as a vaginal formulation for contraceptive use. It works to prevent pregnancy by suppressing ovulation and altering cervical mucus and the endometrial lining.

GNH USA supplies Myprimose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Myprimose, a combined estrogen‑progestogen contraceptive, is indicated for preventing unintended pregnancy. It is used within the hormonal contraception pathway.

- Contraception: provides reliable prevention of pregnancy when used as directed. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns for many users. - Treatment of hormonally‑responsive conditions: may be employed to manage symptoms such as dysmenorrhea or acne associated with hormonal imbalance.

Myprimose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or mild gastrointestinal upset. - Breast tenderness or enlargement. - Headache or migraine episodes. - Spotting or breakthrough bleeding. - Mood changes or irritability. - Weight fluctuation or fluid retention.

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism). - Arterial thrombosis (stroke, myocardial infarction). - Severe hypertension. - Liver disorders, including benign tumors. - Allergic reactions such as rash, angioedema, or anaphylaxis. - Ectopic pregnancy if contraception fails.

Before initiating Myprimose, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Cardiovascular assessment: review history of thromboembolic events, hypertension, or smoking. - Hepatic function: assess liver disease, as metabolism may be impaired. - Smoking status: advise against use in women over 35 who smoke. - Pregnancy avoidance: confirm negative pregnancy test before starting and advise immediate discontinuation if pregnancy occurs. - Missed dose guidance: provide clear instructions on what to do after a missed application. - Storage: Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Myprimose can interact with several medicines that affect hormone metabolism or clotting risk.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin) which may reduce contraceptive efficacy. - Certain antiretroviral agents (e.g., efavirenz) that lower hormone levels. - St. John’s wort, a herbal inducer of hepatic enzymes. - Antifungal agents like ketoconazole when used at high doses.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs) that may increase bleeding tendencies. - Antihypertensive drugs, especially ACE inhibitors, which may affect blood pressure control. - Diuretics, which can alter electrolyte balance. - Anticonvulsants with moderate enzyme‑inducing properties (e.g., valproate). - Herbal supplements such as ginseng that may have variable effects on hormone levels.